Biocon
Biocon is a manufacturer of peptides based in India (Bengaluru). Direct manufacturer. Founded 1978. Key products include peptide APIs, generic APIs.
Listing reviewed October 2026.
About Biocon
Indian biopharmaceutical company making biosimilars, insulins and generic APIs, listed on the Indian stock exchanges. Its generic peptide portfolio covers GLP-1 molecules, with active US Drug Master Files for liraglutide, semaglutide and tirzepatide API.
Directory assessment: Biocon is listed as a manufacturer in the peptide supply chain, serving Asia markets from India (Bengaluru). As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. This profile lists 2 sources for reference. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.
- Semaglutide: DMF 40714 (Type II, active), submitted 2024-12-21
- Tirzepatide: DMF 43038 (Type II, active), submitted 2025-11-24
- Liraglutide: DMF 35968 (Type II, active), submitted 2021-09-01
DMF numbers from the FDA quarterly DMF list. A filed DMF is not FDA approval; its contents are confidential. Reviewed 2026-10-15.